LMR Partners’s Day One Biopharmaceuticals DAWN Stock Holding History

LMR Partners’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-362,641	Closed	-$7.78M	–	1576
2026 Q1	$7.78M	Buy	+362,641	New	+$5.11M	0.02%	504
2021 Q3	–	Sell	-50,000	Closed	-$1.14M	–	1035
2021 Q2	$1.14M	Buy	+50,000	New	+$1.04M	0.02%	497

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

LMR Partners's DAWN Position: Q2 2026 in Review

LMR Partners sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 362,641 shares — an estimated $7.78M sold.

LMR Partners first reported a position in DAWN in Q2 2021 and held it in 2 quarters. The position peaked at $7.78M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

LMR Partners reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
LMR Partners sold 362,641 Day One Biopharmaceuticals shares in Q2 2026, an estimated $7.78M.
LMR Partners first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 2 quarters.
LMR Partners's Day One Biopharmaceuticals position peaked at $7.78M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.